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Abstract
Background: Myocardial contrast echocardiography has been used for determination of infarct
size (IS) in experimental models. However, with intermittent harmonic imaging, IS seems to be
underestimated immediately after reperfusion due to areas with preserved, yet dysfunctional,
microvasculature. The use of exogenous vasodilators showed to be useful to unmask these
infarcted areas with depressed coronary flow reserve. This study was undertaken to assess the
value of adenosine for IS determination in an open-chest canine model of coronary occlusion and
reperfusion, using real-time myocardial contrast echocardiography (RTMCE).
Methods: Nine dogs underwent 180 minutes of coronary occlusion followed by reperfusion.
PESDA (Perfluorocarbon-Exposed Sonicated Dextrose Albumin) was used as contrast agent. IS
was determined by RTMCE before and during adenosine infusion at a rate of 140 mcg·Kg-1·min-1.
Post-mortem necrotic area was determined by triphenyl-tetrazolium chloride (TTC) staining.
Results: IS determined by RTMCE was 1.98 ± 1.30 cm2 and increased to 2.58 ± 1.53 cm2 during
adenosine infusion (p = 0.004), with good correlation between measurements (r = 0.91; p < 0.01).
The necrotic area determined by TTC was 2.29 ± 1.36 cm2 and showed no significant difference
with IS determined by RTMCE before or during hyperemia. A slight better correlation between
RTMCE and TTC measurements was observed during adenosine (r = 0.99; p < 0.001) then before
it (r = 0.92; p = 0.0013).
Conclusion: RTMCE can accurately determine IS in immediate period after acute myocardial
infarction. Adenosine infusion results in a slight better detection of actual size of myocardial
damage.
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Background
IS can be determined by myocardial contrast echocardiog-
raphy after a period of coronary ischemia and reperfusion,
by exploiting the "no-reflow" state of necrotic tissue [1-4].
In this setting, fewer microbubbles enter the necrotic zone
because of functional and/or structural damage to the cor-
onary capillaries, resulting in a hypoperfused region that
can be detected by this non-invasive method [5]. How-
ever, previous studies using intermittent harmonic imag-
ing demonstrated that IS can be underestimated by
myocardial contrast echocardiography immediately after
coronary reperfusion, because in some regions the micro-
vascular damage occurs later than myocyte death, result-
ing in relatively preserved perfusion in infarcted areas [6-
8]. In this setting, exogenous vasodilatation has proven to
be useful to unmask necrotic area with abnormal microv-
ascular coronary flow reserve, providing a more accurate
assessment of IS.
RTMCE is a technique that uses very low mechanical
energy and, thus, allows the observation of real-time myo-
cardial perfusion as a result of reduced background-tissue
interference. Therefore, it is possibly the ideal tool for the
evaluation of dynamic changes that occur in coronary
blood flow and simultaneous evaluation of myocardial
function [9]. This study was undertaken to assess the addi-
tional value of exogenous vasodilation with adenosine for
IS determination using RTMCE, in an open-chest canine
model of coronary occlusion and reperfusion.
Methods
Animal preparation
The protocol was conformed to the American Heart Asso-
ciation Guidelines for Animal Research Use. Twelve mon-
grel dogs weighting 12 to 20 Kg were anesthetized with
sodium pentobarbital (30 mg·kg-1 body weight), intu-
bated and mechanically ventilated. Additional anesthesia
was administered during the experiment as needed. A 7F
catheter was positioned in the left carotid artery for mon-
itoring systemic arterial pressure, connected to a Biopac
Systems device (Biopac Systems, California), and another
7F catheter was introduced into the jugular vein for drug
infusions and volemic control.
A left lateral thoracotomy was performed, and the heart
suspended in a pericardial cradle. The proximal left ante-
rior descending coronary artery (LAD) was then dissected
free from the surrounding tissue, and, at the time of coro-
nary occlusion, an occluder was placed around of it. A two
millimeter transit-time ultrasound probe (Transonic Sys-
tems, Inc, Probe 2SB839) was placed around the LAD,
proximal to the occluder, and connected to a digital flow-
meter for epicardial coronary flow measurements.
Myocardial contrast echocardiography
Myocardial contrast echocardiography was performed
with a real-time ultrasound system (HDI 5000 – Philips
Medical Systems) equipped with a 4-2 MHz transducer.
Images were acquired in the longitudinal apical view by
using a water-filled latex interface between anterior epicar-
dium and the transducer. Power Pulse Inversion imaging
was adjusted before contrast injection to minimize the
clutter artifact due to cardiac motion. Specific instrumen-
tation settings included: mechanical index ranging from
0.09 to 0.12 (usually 0.1), low dynamic range and maxi-
mal line density. After adjustment, all parameters, includ-
ing depth, focal point and gain, were held constant for
each experiment. Manually triggered, transient, high
mechanical index imaging ("Flash" imaging) was defla-
grated at peak contrast intensity to destroy microbubbles
within the myocardium, exclude artifacts and allow the
evaluation of myocardial replenishment (Figure 1) [10].
The contrast agent used was Perfluorocarbon-Exposed
Sonicated Dextrose Albumin (PESDA), prepared in our
laboratory according to previous description [11]. Briefly,
8 ml of Decafluorobutane gas (Fluoromed Corporation,
Round Rock, Texas, USA) were hand agitated with a 3:1
mixture of 5% dextrose and 5% human serum albumin.
This mixture was then sonicated for 80 seconds. The mean
concentration of microbubbles produced was 1.4 × 109
microbubbles/ml with a mean size of 4.6 ± 0.2 microns. A
total of 0.1 ml/Kg of PESDA was diluted in 80 ml of 0.9%
saline and administered by continuous intravenous infu-
sion. The infusion was increased to a rate of 1–3 ml·min-
1, and adjusted so that there was good opacification of left
Example of a baseline representative study showing real-time  myocardial contrast echocardiography with flash imaging  used to cause myocardial microbubble destruction on the  left, followed by absence of myocardial contrast in post-flash  imaging (middle) and myocardial replenishment on the  right, where complete and homogeneous myocardial per- fusion can be observed Figure 1
Example of a baseline representative study showing real-time 
myocardial contrast echocardiography with flash imaging 
used to cause myocardial microbubble destruction on the 
left, followed by absence of myocardial contrast in post-flash 
imaging (middle) and myocardial replenishment on the 
right, where complete and homogeneous myocardial per-
fusion can be observed. Sequences of myocardial replenishe-
ment were acquired at baseline, during coronary occlusion, 
after 30 minutes of reperfusion and with adenosine infusion.Cardiovascular Ultrasound 2006, 4:10 http://www.cardiovascularultrasound.com/content/4/1/10
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ventricular cavity and adequate myocardial perfusion
imaging.
Experimental protocol
Baseline RTMCE was obtained when hemodynamic sta-
bility had been achieved. LAD was then totally occluded
for 180 minutes, with confirmation of absent coronary
flow by electromagnetic flowmeter with continuous mon-
itoring of hemodynamics. The occluder was then with-
drawn and, at 30 minutes of reperfusion, myocardial wall
motion (WM) and perfusion was analysed using RTMCE
once coronary flow had reached a constant rate. Image
acquisition was performed before and after a four-min-
utes intravenous infusion of adenosine at a rate of 140
mcg·Kg-1·min-1, using a infusion pump.
Imaging analysis
The complete sequence of flash imaging with high energy
followed by subsequent myocardial refilling was acquired
and stored on VHS videotape and optical disk for off-line
processing and analysis. Sequences were acquired at reper-
fusion and compared to baseline to identify perfusional
abnormalities.
IS was defined by RTMCE as the residual perfusional myo-
cardial defect area after coronary reperfusion, before and
during adenosine infusion, and compared to tissue stain-
ing [12]. At the moment of maximal myocardial contrast
replenishment, the borders of perfusion defects were vis-
ually identified as the largest area with clearly diminished
opacification, and measured by digital planimetry, in a
single end-diastolic frame.
Blood pressure, heart rate and LAD flow were collected at
baseline, at 180 minutes of occlusion, at 30 minutes of
reperfusion and during adenosine. IS was determined by
two observers blinded of tissue staining measurements in
all dogs.
Hystological staining
After completion of the protocol, animals were eutha-
nized and had their heart excised. The LAD was again
occluded at the same site and cannulated immediately
after occlusion. Ostium of the right coronary artery and
the left main branch were also cannulated. Evans blue dye
(1 mg·Kg-1) was infused in the right coronary artery and
left main branch and, simultaneously, a 2% solution of
2.3.5-triphenyl-tetrazolium chloride (TTC) was injected
into LAD, during 5 minutes. The heart was then sectioned
longitudinally, passing through aortic valve and cardiac
apex and incubated into TTC at 37°C for 30 minutes. This
technique stains viable myocardium brick red and spares
necrotic tissue. Regions that failed to demonstrate brick
red staining, appearing pale yellow, were considered
necrotic myocardium [13]. Evans blue stained of blue the
regions not perfused by LAD and, therefore, defined the
risk area. The TTC-stained slice correspondent to that of
echocardiographic apical longitudinal view was digital-
Table 2: Infarct size area determined by real-time myocardial contrast echocardiography (RTMCE) before and during adenosine 
infusion, and by triphenyl-tetrazolium chloride (TTC) staining
Infarct Size (cm2)
RTMCE Before Adenosine RTMCE During Adenosine TTC staining
Dog 1 0.88 0.98 0.93
Dog 2 1.49 1.54 1.51
Dog 3 1.83 1.97 1.97
Dog 4 1.26 1.86 1.78
Dog 5 1.62 2.36 2.18
Dog 6 4.48 5.14 4.84
Dog 7 3.85 5.05 4.16
Dog 8 0.74 1.38 1.08
Dog 9 1.70 2.95 3.02
Table 1: Hemodynamic data at baseline, at 180 minutes of coronary occlusion and at 30 minutes of reperfusion, before and during 
adenosine infusion.
Baseline LAD Occlusion Reperfusion Reperfusion + adenosine
HR (beats·min-1) 124 ± 12 112 ± 24 107 ± 24 106 ± 23
Mean ABP (mmHg) 87 ± 15 87 ± 19 78 ± 19 77 ± 18
LAD Flow (ml·min-1) 21.1 ± 5.3 ------ 21.2 ± 5.7* 19.9 ± 6.0†
Values are mean ± SD. ABP = arterial blood pressure, LAD = left anterior descending coronary artery, HR = heart rate. * p = NS between baseline 
and reperfusion. † p < 0.05 between baseline and reperfusion + adenosine.Cardiovascular Ultrasound 2006, 4:10 http://www.cardiovascularultrasound.com/content/4/1/10
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ized into an off-line computer and the necrotic area was
calculated by planimetry.
Statistical analysis
Continuous and normally distributed data were expressed
as mean ± one standard deviation (SD) and qualitative
data as proportions. Within-groups comparisons were
performed by paired Student's t test, repeated-measures
analysis of variance or Friedman's test, as appropriate.
Correlations between the RTMCE before and during ade-
nosine and tissue staining were performed by linear
regression using Spearman's rank statistic and agreement
analysis as proposed by Bland and Altman. A p value <
0.05 (two-sided) was considered statistically significant.
Results
Three dogs had ventricular fibrillation and were excluded
from the study. The protocol was successfully performed
in the remaining nine dogs (mean weight of 15.8 ± 2.3
Kg). Technically adequate contrast imaging was obtained
in all animals.
Hemodynamic data
Hemodynamic data are summarized in Table 1. Mean
arterial blood pressure and heart rate remained stable dur-
ing the entire occlusion and reperfusion stages. The epi-
cardial LAD flow reduced to zero during LAD occlusion.
In the first minute of reperfusion, we observed a period of
reactive hyperemia with an increase of 2.6 times (54.3 ±
25.6 ml·min-1) the baseline LAD flow. At 30 minutes of
reperfusion, LAD flow had already returned to baseline
levels. Intravenous infusion of PESDA caused no signifi-
cant changes in baseline hemodynamic values.
Determination of IS by RTMCE and tissue staining
At baseline, both left ventricular wall thickening and myo-
cardial perfusion were normal in all dogs. We observed
wall motion abnormalities and perfusional defects in the
area supplied by LAD soon after coronary occlusion. IS
determined by RTMCE 30 minutes after coronary reper-
fusion was 1.98 ± 1.30 cm2, and increased to 2.58 ± 1.53
cm2 during adenosine infusion (p = 0.004). Adenosine
consistently resulted in a slightly greater area of IS (see
Table 2 for details), with a strong correlation of measure-
ments before and after its use (Figure 2). Infarcted area
was localized mostly in the subendocardium, inside the
region supplied by LAD, and in the correspondent area of
necrotic tissue as determined by TTC staining (Figure 3).
The necrotic myocardial area determined by TTC staining
was 2.29 ± 1.36 cm2. There was nor a significant differ-
ence between IS determined by RTMCE before adenosine
and TTC (p = 0.53) or during adenosine and TTC (p =
0.78). There was a strong correlation between RTMCE and
TTC measurements both before (IS by TTC = 1.00 × IS by
RTMCE + 0.40; r = 0.92, p = 0.0013) and during adenos-
ine infusion (IS by TTC = 0.87 × IS by RTMCE with adeno-
sine + 0.13; r = 0.99, p < 0.001), as demonstrated in Figure
4. However, a better concordance between the two meas-
urements was observed with the use of exogenous vasodi-
lator (Figure 5).
Representative example of real-time myocardial contrast  echocardiography images showing lack of perfusion that cor- responds to infarcted area before (A) and during adenosine  infusion (small arrows) (B) Figure 3
Representative example of real-time myocardial contrast 
echocardiography images showing lack of perfusion that cor-
responds to infarcted area before (A) and during adenosine 
infusion (small arrows) (B). Note that adenosine increases 
the infarct size determination. Necrotic area was determined 
as the region that failed to demonstrate brick red staining, 
appearing pale yellow, by triphenyl-tetrazolium chloride 
staining (arrow) (C).
Correlation between infarct size (IS) determined by real-time  myocardial contrast echocardiography before and during  adenosine infusion Figure 2
Correlation between infarct size (IS) determined by real-time 
myocardial contrast echocardiography before and during 
adenosine infusion.Cardiovascular Ultrasound 2006, 4:10 http://www.cardiovascularultrasound.com/content/4/1/10
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Interobserver variability
Measurements of IS evaluated by the two independent
observers showed a good concordance. Before adenosine
infusion, the interobserver variability, expressed by the
relative mean error, was 2.7% whereas during adenosine
infusion it was 9.4%.
Discussion
Although some studies have already evaluated the use of
RTMCE for assessment of myocardial perfusion after acute
myocardial infarction [14], the role of exogenous vasodil-
atation in this setting is not well established. Our study
confirmed previously described findings reporting that, in
experimental model of infarction, RTMCE is capable of
determining IS accurately after coronary reperfusion,
instead of disparity between abnormal WM and IS at rest
and perfusional defect during demand ischemia that was
explained by the presence of collateral blood flow [15].
During adenosine infusion, we observed an increase in
perfusional defect, resulting in a better correlation
between the echocardiographic measurements and the
necrotic area determined by tissue staining. Actually, ade-
nosine infusion unmasked a very small region of infarcted
myocardium, which was surrounding the central necrotic
tissue area.
It is well known that in the immediate period after acute
infarction, myocardium within the reperfusion to the
ischemic bed is variable. Irreversibly injured myocardium
is generally associated with loss of microvascular integrity,
which is proportional to the extension and severity of
myocellular necrosis [16]. However, because of the wave-
front nature of myocardial damage following a prolonged
period of ischemia, a mismatch between microvascular
and myocyte necrosis can occur, resulting in areas of cel-
lular death with relatively preserved perfusion [1]. In the
poorly perfused areas, severe capillary damage and coagu-
lation necrosis can be observed, but microvascular dam-
age might also develop during reperfusion. Due to its
ability to remain entirely within intravascular space,
microbubbles used as echocardiographic contrast agents
are markers of blood flow and allows a non-invasive eval-
uation of microvascular integrity. Previous studies of
myocardial contrast echocardiography have shown that,
after infarct-related artery reperfusion, the spatial distribu-
tion of myocardial perfusional defects varies with time
and by itself can underestimate the degree of necrosis. In
these cases, regions within infarcted area with preserved
microvasculature but depressed flow reserve can be
unmasked by infusion of an exogenous vasodilator [5].
On the other hand, it was also previously demonstrated in
experimental studies, that RTMCE can accurately deline-
ate risk area and IS after reperfusion. With this technique,
the size of an opacification defect varies with the period of
time available for myocardial refilling by microbubbles
[12]. Therefore, the infarct area should be determined at
the end of the myocardial refilling sequence.
Our findings are that the analysis of myocardial perfusion
by RTMCE slightly underestimated the IS, while the addi-
tion of adenosine resulted in a better correlation with
TTC. However, we would like to emphasize that correla-
tion between RTMCE and TTC was good even before ade-
nosine infusion. Some mechanisms should be considered
when analyzing possible factors related to the better IS
determination using RTMCE than previously related
reports using intermittent imaging techniques [3]. It is
important to note that the combination of intravenous
continuous infusion of a perfluorocarbon-based micro-
bubble and a low energy imaging modality allow infusion
of small quantities of contrast agent, avoiding over-satura-
tion of microbubbles and reducing blooming effects. In
contrast, some initial studies used intraaortic injection of
air-filled microbubbles as echocardiographic agent,
resulting in a higher concentration of microbubbles in the
microcirculation, and, perhaps, leading to an over satura-
tion of contrast [3,6]. Another reasonable associated
mechanism for these findings would be the longer inter-
val required for each acquisition when using intermittent
imaging. In this modality of imaging, ultrasound pulses
are emitted intermittently and triggered by electrocardio-
gram, and this longer period of time between imaging
could allow the opacification of areas with infarcted myo-
cardium but still preserved microcirculation. In this con-
text, the benefits of vasodilator use have already been
established since they unmask dysfunctional microvascu-
lature. In the current study we analyzed the destruction/
Correlation between infarct size (IS) determined by real-time  myocardial contrast echocardiography (RTMCE) without  adenosine (triangles) and during adenosine infusion (cir- cles) and by triphenyl-tetrazolium chloride (TTC) staining Figure 4
Correlation between infarct size (IS) determined by real-time 
myocardial contrast echocardiography (RTMCE) without 
adenosine (triangles) and during adenosine infusion (cir-
cles) and by triphenyl-tetrazolium chloride (TTC) staining.Cardiovascular Ultrasound 2006, 4:10 http://www.cardiovascularultrasound.com/content/4/1/10
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refilling curves derived from low-energy real-time imag-
ing. It seems that this technique provides a good determi-
nation of myocardial perfusion, even without vasodilator
use.
Magnetic resonance imaging with gadolinium-based con-
trast was been demonstrated a precise method for deter-
mining IS and its transmurality [17,18]. Magnetic
resonance imaging offers high spatial resolution and can
identify non-viable tissue using delayed enhancement
technique. However, its cost and availability limit the
widespread use of this technique. RTMCE is a non-radio-
logic modality of imaging that permits the evaluation of
patients at bedside, and has the advantage of providing
rapid information regarding myocardial contraction and
perfusion. Strain rate imaging is another echocardio-
graphic imaging that has been recently shown useful for
differentiating transmural from non-transmural myocar-
dial infarction in a small number of patients [19].
Limitations
IS estimation has been demonstrated limited immediately
after reperfusion because of reactive hyperemia that
occurs shortly after reperfusion and abates within hours
[20]. Previous studies have demonstrated that myocardial
contrast echocardiography with intermittent harmonic
imaging performed after twelve hours of reperfusion pro-
vides an accurate assessment of infarct size [21]. One
could argue that the period in which myocardial per-
fusion was evaluated in our study was too close after LAD
reperfusion (30 min). However, the study was designed to
determine the value of RTMCE in a period of time in
which reactive hyperemia is known to occur [20].
The assessment of IS by two-dimensional contrast
echocardiography was performed using a single tomo-
graphic plane. Consequently, the measurements obtained
by RTMCE and tissue staining represent an estimation of
the true spatial extent of infarcted myocardium. However,
since the aim of this study was a direct comparison
between IS determined before and during adenosine with
anatomical area, this issue is minimized. Of note, previ-
ous animal studies validated the good agreement between
echocardiographic measurements and anatomic findings
of risk area as well as IS using the methodology employed
in this study [22,23].
Our results are based on visual assessment of perfusion
defects and their measurements by planimetry. Although
myocardial blood flow quantification can provide infor-
mation about myocardial viability after reperfusional
therapy, we considered that it was not necessary for the
design of this study.
Clinical implications
A prompt definition of the efficacy of reperfusion therapy
as well as the extent of its residual microvascular damage
by a non-invasive method has important implications for
the management of patients with acute myocardial infarc-
tion. Also, the presence of preserved microvascular flow in
the post-reperfusion period is associated with a lower rate
of fibrous scar and less ventricular remodeling [2,24]. Our
study showed that RTMCE can provide a reliable estima-
tive of IS by visual evaluation, even without the infusion
of exogenous vasodilator. This seems to be an important
contribution for the clinical application of myocardial
contrast echocardiography in the emergency room to
Bland-Altman plots showing mean difference (solid line) and limits of agreement (dashed lines) between infarct size (IS) deter- mined by triphenyl-tetrazolium (TTC) staining and real-time myocardial contrast echocardiography (RTMCE) without adenos- ine (A) and during adenosine infusion (B) Figure 5
Bland-Altman plots showing mean difference (solid line) and limits of agreement (dashed lines) between infarct size (IS) deter-
mined by triphenyl-tetrazolium (TTC) staining and real-time myocardial contrast echocardiography (RTMCE) without adenos-
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delineate IS in the setting of acute myocardial infarction,
since some patients may present in a hemodynamically
unstable period after reperfusional therapy, precluding
the use of adenosine.
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